参考文献/References:
［1］ HORVATH P,BARRANGOU R.CRISPR/Cas,the immune system of bacteria and archaea［J］.Science,2010,327(5962):167-170.
［2］ HSU P D,LANDER E S,ZHANG F.Development and applications of CRISPR-Cas9 for genome engineering［J］.Cell,2014,157(6):1262-1278.
［3］ HEYER W D,EHMSEN K T,LIU J.Regulation of homologous recombination in eukaryotes［J］.Annu Rev Genet,2010,44,113-139.
［4］ LIEBER M R,GU J,LU H,et al.Nonhomologous DNA end joining (NHEJ) and chromosomal translocations in humans［J］.Subcell Biochem,2010,50：279-296.
［5］ JINEK M,CHYLINSKI K,FONFARA I,et al.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity［J］.Science,2012,337(6096):816-821.
［6］ JIANG W,ZHOU H,BI H,et al.Demonstration of CRISPR/Cas9/sgRNA-mediated targeted gene modification in Arabidopsis,tobacco,sorghum and rice［J］.Nucleic Acids Res,2013,41(20):e188.
［7］ YU Z,REN M,WANG Z,et al.Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila［J］.Genetics,2013,195(1):289-291.
［8］ JIANG W,BIKARD D,COX D,et al.RNA-guided editing of bacterial genomes using CRISPR-Cas systems［J］.Nat Biotechnol,2013,31(3):233-239.
［9］ WANG X,ZHOU J,CAO C,et al.Efficient CRISPR/Cas9-mediated biallelic gene disruption and site-specific knocking after rapid selection of highly active sgRNAs in pigs［J］.Sci Rep,2015,5:13348.
［10］ HWANG W Y,FU Y F,REYON D,et al.Efficient genome editing in zebrafish using a CRISPR-Cas system［J］.Nat Biotechnol,2013,31(3):227-229.
［11］ NAKAYAMA T,FISH M B,FISHER M,et al.Simple and efficient CRISPR/Cas9- mediated targeted mutagenesis in Xenopus tropicalis［J］.Genesis,2013,51(12):835-843.
［12］ LI D,QIU Z,SHAO Y,et al.Heritable gene targeting in the mouse and rat using a CRISPR-Cas system［J］.Nat Biotechnol,2013,31(8):681-683.
［13］ NIU Y,SHEN B,CUI Y,et al.Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos［J］.Cell,2014,156(4):836-843.
［14］ LIANG P,XU Y,ZHANG X,et al.CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes［J］.Protein Cell,2015,6(5):363-372.
［15］ SHINMYO Y,TANAKA S,TSUNODA S,et al.CRISPR/Cas9-mediated gene knockout in the mouse brain using in utero electroporation［J］.Sci Rep,2016,6:20611.
［16］ GANDHI S,PIACENTINO M L,VIECELI F M,et al.Optimization of CRISPR/Cas9 genome editing for loss-of-function in the early chick embryo［J］.Dev Biol,2017,432(1):86-97.
［17］ ROH J I,LEE J,PARK S U,et al.CRISPR-Cas9-mediated gene-ration of obese and diabetic mouse models［J］.Exp Anim,2018,67(2):229-237.
［18］ RASYS A M,PARK S,BALL R E,et al.CRISPR-Cas9 gene editing in lizards through microinjection of unfertilized oocytes［J］.Cell Rep,2019,28(9):2288-2292 e3.
［19］ BYAMBAA S,UOSAKI H,HARA H,et al.Generation of novel Il2rg-knockout mice with clustered regularly interspaced short palindromic repeats (CRISPR) and Cas9［J］.Exp Anim,2020,69(2):189-198.
［20］ WU Y,LIANG D,WANG Y,et al.Correction of a genetic disease in mouse via use of CRISPR-Cas9［J］.Cell Stem Cell,2013,13(6):659-662.
［21］ YIN H,XUE W,CHEN S,et al.Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype［J］.Nat Biotechnol,2014,32(6):551-553.
［22］ SCHUMANN K,LIN S,BOYER E,et al.Generation of knock-in primary human T cells using Cas9 ribonucleoproteins［J］.Proc Natl Acad Sci U S A,2015,112(33):10437-10442.
［23］ YANG Y,WANG L,BELL P,et al.A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice［J］.Nat Biotechnol,2016,34(3):334-338.
［24］ GUAN Y,MA Y,LI Q,et al.CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse［J］.EMBO Mol Med,2016,8(5):477-488.
［25］ KOLLI N,LU M,MAITI P,et al.CRISPR-Cas9 mediated gene-silencing of the mutant huntingtin gene in an in vitro model of Huntington′s disease［J］.Int J Mol Sci,2017,18(4):754.
［26］ YANG S,CHANG R,YANG H,et al.CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington′s disease［J］.J Clin Invest,2017,127(7):2719- 2724.
［27］ GYRGY B,LV C,ZABOROWSKI M P,et al.CRISPR/Cas9 mediated disruption of the Swedish APP allele as a therapeutic approach for early-onset Alzheimer′s disease［J］.Mol Ther Nucleic Acids,2018,11:429-440.
［28］ EKMAN F K,OJALA D S,ADIL M M,et al.CRISPR-Cas9-mediated genome editing increases lifespan and improves motor deficits in a Huntington′s disease mouse model［J］.Mol Ther Nucleic Acids,2019,17:829-839.
［29］ PINZON-ARTEAGA C,SNYDER M D,LAZZAROTTO C R,et al.Efficient correction of a deleterious point mutation in primary horse fibroblasts with CRISPR-Cas9［J］.Sci Rep,2020,10(1):7411.
［30］ QI L S,LARSON M H,GILBERT L A,et al.Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression［J］.Cell,2013,152(5):1173-1183.
［31］ LARSON M H,GILBERT L A,WANG X,et al.CRISPR inter-ference (CRISPRi) for sequence-specific control of gene expre-ssion［J］.Nat Protoc,2013,8(11):2180-2196.
［32］ BIKARD D,JIANG W,SAMAI P,et al.Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system［J］.Nucleic Acids Res,2013,41(15):7429-7437.
［33］ ZHAO Y,DAI Z,LIANG Y,et al.Sequence-specific inhibition of microRNA via CRISPR/ CRISPRi system［J］.Sci Rep,2014,4:3943.
［34］ SUN Y,ORAVECZ-WILSON K,MATHEWSON N,et al.Mature T cell responses are controlled by microRNA-142［J］.J Clin Invest,2015,125(7):2825-2840.
［35］ HEMAN-ACKAH S M,BASSETT A R,WOOD M J.Precision modulation of neurodegenerative disease-related gene expression in human iPSC-derived neurons［J］.Sci Rep,2016,6:28420.
［36］ LIU S J,HORLBECK M A,CHO S W,et al.CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells［J］.Science,2017,355(6320):aah7111.
［37］ YOSHIDA M,YOKOTA E,SAKUMA T,et al.Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma［J］.Oncotarget,2018,9(49):29220-29232.
［38］ WANG X,MA S,LIU Y,et al.Transcriptional repression of endo-genous genes in BmE cells using CRISPRi system［J］.Insect Biochem Mol Biol,2019,111:103172.
［39］ HAZELBAKER D Z,BECCARD A,ANGELINI G,et al.A multiplexed gRNA piggyBac transposon system facilitates efficient induction of CRISPRi and CRISPRa in human pluripotent stem cells［J］.Sci Rep,2020,10(1):635.
［40］ MAEDER M L,LINDER S J,CASCIO V M,et al.CRISPR RNA-guided activation of endogenous human genes［J］.Nat Methods,2013,10(10):977-979.
［41］ GAO X,TSANG J C,GABA F,et al.Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers［J］.Nucleic Acids Res,2014,42(20):e155.
［42］ NIHONGAKI Y,YAMAMOTO S,KAWANO F,et al.CRISPR-Cas9-based photoactivatable transcription system［J］.Chem Biol,2015,22(2):169-174.
［43］ POLSTEIN L R,GERSBACH C A.A light-inducible CRISPR-Cas9 system for control of endogenous gene activation［J］.Nat Chem Biol,2015,11(3):198-200.
［44］ ZETSCHE B,VOLZ S E,ZHANG F.A split-Cas9 architecture for inducible genome editing and transcription modulation［J］.Nat Biotechnol,2015,33(2):139-142.
［45］ LI S,ZHANG A,XUE H,et al.One-step piggyBac transposon-based CRISPR/Cas9 activation of multiple genes［J］.Mol Ther Nucleic Acids,2017,8:64-76.
［46］ PUTRI R R,CHEN L.Spatiotemporal control of zebrafish (Danio rerio) gene expression using a light-activated CRISPR activation system［J］.Gene,2018,677:273-279.
［47］ MATHARU N,RATTANASOPHA S,TAMURA S,et al.CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency［J］.Science,2019,363(6424):eaau0629.
［48］ COLASANTE G,QIU Y,MASSIMINO L,et al.In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy［J］.Brain,2020,143(3):891-905.
［49］ ZHANG F,WEN Y,GUO X.CRISPR/Cas9 for genome editing:progress,implications and challenges［J］.Hum Mol Genet,2014,23(R1):R40-46.
［50］ FU Y,FODEN J A,KHAYTER C,et al.High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells［J］.Nat Biotechnol,2013,31(9):822-826.
［51］ NAITO Y,HINO K,BONO H,et al.CRISPRdirect:software for designing CRISPR/Cas guide RNA with reduced off-target sites［J］.Bioinformatics,2015,31(7):1120-1123.
［52］ SLAYMAKER I M,GAO L,ZETSCHE B,et al.Rationally engineered Cas9 nucleases with improved specificity［J］.Science,2016,351(6268):84-88.
［53］ SHEN C C,HSU M N,CHANG C W,et al.Synthetic switch to minimize CRISPR off-target effects by self-restricting Cas9 transcription and translation［J］.Nucleic Acids Res,2019,47(3):e13.